Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mitotic kinetochore forms at the centromere for proper chromosome segregation. Deposition of the centromere-specific histone H3 variant, spCENP-A/Cnp1, is vital for the formation of centromere-specific chromatin and the Mis17-
Mis6
complex of the fission yeast
Schizosaccharomyces pombe
is required for this deposition. Here we identified extragenic suppressors for a Mis17-
Mis6
complex temperature-sensitive (ts) mutant,
mis17-S353P
, using whole-genome sequencing. The large and small daughter nuclei phenotype observed in
mis17-S353P
was greatly rescued by these suppressors. Suppressor mutations in two
ribonuclease
genes involved in the mRNA decay pathway,
exo2
and
pan2
, may affect Mis17 protein level, as
mis17
mutant protein level was recovered in
mis17-S353P exo2
double mutant cells. Suppressor mutations in EKC/KEOPS complex genes may not regulate Mis17 protein level, but restored centromeric localization of spCENP-A/Cnp1,
Mis6
and Mis15 in
mis17-S353P
Therefore, the EKC/KEOPS complex may inhibit Mis17-
Mis6
complex formation or centromeric localization. Mutational analysis in protein structure indicated that suppressor mutations in the EKC/KEOPS complex may interfere with its kinase activity or complex formation. Our results suggest that the mRNA decay pathway and the EKC/KEOPS complex negatively regulate Mis17-
Mis6
complex-mediated centromere formation by distinct and unexpected mechanisms.
...
PMID:Negative Regulation of the Mis17-Mis6 Centromere Complex by mRNA Decay Pathway and EKC/KEOPS Complex in
Schizosaccharomyces pombe
. 3096 22